Economic and clinical implications of metabolic dysfunction-associated steatotic liver disease management: Regional challenges and opportunities in Middle East and North Africa

This commentary examines the growing clinical and financial toll of metabolic dysfunction-associated steatotic liver disease across the Middle East and North Africa. It calls attention to the region's specific challenges in screening, treatment access, and health-system planning, framing them as opportunities for coordinated policy action.